(Q38305554)

2 September 2017

1 reference

title

Ganciclovir--a review of pharmacology, therapeutic efficacy and potential use for treatment of congenital cytomegalovirus infections (English)

1 reference

2 September 2017

0 references

0 references

Fan-Havard P

1

1 reference

PubMed ID

2555373

2 September 2017

Nahata MC

series ordinal

2

1 reference

PubMed ID

2555373

2 September 2017

Brady MT

series ordinal

3

1 reference

2 September 2017

1 October 1989

1 reference

Journal of Clinical Pharmacy and Therapeutics

2 September 2017

1 reference

2 September 2017

14

1 reference

2 September 2017

329-340

1 reference

2 September 2017

5

1 reference

Sequelae of maternally derived cytomegalovirus infections in premature infants

2 September 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.1989.TB00256.X

Protracted pneumonitis in young infants associated with perinatally acquired cytomegaloviral infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.1989.TB00256.X

Infection in the renal transplant recipient.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.1989.TB00256.X

A Prospective Analysis of Interstitial Pneumonia and Opportunistic Viral Infection among Recipients of Allogeneic Bone Marrow Grafts

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.1989.TB00256.X

Cytomegalovirus Pneumonia After Human Marrow Transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.1989.TB00256.X

Increased Pulmonary Superinfections in Cardiac-Transplant Patients Undergoing Primary Cytomegalovirus Infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.1989.TB00256.X

Epidemiology of Cytomegalovirus Infection after Transplantation and Immunosuppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.1989.TB00256.X

Cytomegalovirus inclusion disease at autopsy of patients with cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.1989.TB00256.X

Cytomegalovirus Infection in Patients Receiving Immunosuppressive Therapy for Rheumatologic Disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.1989.TB00256.X

Cytomegalovirus Infections Associated with Leukocyte Transfusions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.1989.TB00256.X

Cytomegalovirus encephalitis in adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.1989.TB00256.X

Congenital cytomegalovirus infection: a fifteen year perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.1989.TB00256.X

The use of acyclovir for cytomegalovirus infections in the immunocompromised host

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.1989.TB00256.X

Synthesis and antiherpes virus activity of phosphate and phosphonate derivatives of 9-[(1,3-dihydroxy-2-propoxy)methyl]guanine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.1989.TB00256.X

Acyclovir. Pharmacology and clinical experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.1989.TB00256.X

9-([2-hydroxy-1-(hydroxymethyl)ethoxy]methyl)guanine: a selective inhibitor of herpes group virus replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.1989.TB00256.X

Effect of 9-(1,3-dihydroxy-2-propoxymethyl)guanine on human cytomegalovirus replication in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.1989.TB00256.X

Activity of 9-(1,3-dihydroxy-2-propoxymethyl)guanine compared with that of acyclovir against human, monkey, and rodent cytomegaloviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.1989.TB00256.X

Unique spectrum of activity of 9-[(1,3-dihydroxy-2-propoxy)methyl]-guanine against herpesviruses in vitro and its mode of action against herpes simplex virus type 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.1989.TB00256.X

Human pharmacokinetics of the antiviral drug DHPG.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.1989.TB00256.X

Activity of 9-[2-hydroxy-1-(hydroxymethyl)ethoxymethyl]guanine in the treatment of cytomegalovirus pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.1989.TB00256.X

Treatment of cytomegalovirus retinitis with 9-[2-hydroxy-1-(hydroxymethyl)ethoxymethyl]guanine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.1989.TB00256.X

Cytomegalovirus infection of the alimentary canal: radiologic findings with pathologic correlation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.1989.TB00256.X

Intestinal infections in patients with the acquired immunodeficiency syndrome (AIDS). Etiology and response to therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.1989.TB00256.X

Treatment of cytomegalovirus pneumonitis after bone marrow transplantation with 9-[2-hydroxy-1-(hydroxymethyl) ethoxymethyl] guanine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.1989.TB00256.X

Congenital cytomegalovirus infection. Developmental progress of infants detected by routine screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.1989.TB00256.X

Acquired immune deficiency syndrome in childhood

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.1989.TB00256.X

Acquired immunodeficiency syndrome in infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.1989.TB00256.X

Treatment of serious cytomegalovirus infections with 9-(1,3-dihydroxy-2-propoxymethyl)guanine in patients with AIDS and other immunodeficiencies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.1989.TB00256.X

10.1111/J.1365-2710.1989.TB00256.X

21 January 2018

Identifiers

DOI

1 reference

2 September 2017

1 reference

PubMed ID

2555373